Standout Papers

Trastuzumab Deruxtecan in Previously Tr... 2011 2026 2016 2021 748
  1. Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer (2020)
    Kohei Shitara, Yung‐Jue Bang et al. New England Journal of Medicine
  2. Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial (2011)
    Jeeyun Lee, Do Hoon Lim et al. Journal of Clinical Oncology
  3. Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone (2012)
    Jung Hun Kang, Soon Il Lee et al. Journal of Clinical Oncology
  4. Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA (2015)
    Richard B. Lanman, Stefanie Mortimer et al. PLoS ONE
  5. Gastric adenocarcinoma (2017)
    Jaffer A. Ajani, Jeeyun Lee et al. Nature Reviews Disease Primers
  6. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses (2015)
    Se Hoon Park, Tae Sung Sohn et al. Journal of Clinical Oncology

Immediate Impact

13 from Science/Nature 74 standout
Sub-graph 1 of 21

Citing Papers

Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
4 intermediate papers

Works of Jeeyun Lee being referenced

Phase 2 study of bavituximab (bavi), a first-in-class antibody targeting phosphatidylserine (PS), plus pembrolizumab (P) in advanced gastric or gastroesophageal junction (GEJ) cancer.
2023
Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma
2020
and 4 more

Author Peers

Author Last Decade Papers Cites
Jeeyun Lee 7417 6559 3348 502 14.0k
Joon Oh Park 9002 7439 4426 378 15.8k
Antoîne Italiano 8717 8842 3815 606 16.8k
Jayesh Desai 7478 4816 3363 317 12.9k
Isabelle Ray‐Coquard 6720 4876 2749 390 15.4k
Won Ki Kang 5792 5912 2493 344 11.8k
Patrick Schöffski 9407 9276 4736 500 18.9k
Michael J. Overman 10938 3816 2587 443 15.9k
Silvana Pilotti 6524 5255 5054 293 15.9k
Ho Yeong Lim 6235 5478 3371 365 14.2k
Toshihiko Doi 9051 6183 2501 421 13.9k

All Works

Loading papers...

Rankless by CCL
2026